European Association For NeuroOncology 11th Meeting 2014 (EANO 2014)
Centro Congressi Lingotto *Torino, ITALY Visit the Venue to read more
Dear Colleague, dear Friend,
The Italian Association of Neuro-Oncology (AINO) is honoured to host the 11th EANO 2014 meeting in Turin, and invites you to join this outstanding event for neurooncology in Europe and worldwide. Over the last two decades there has been an explosive growth of knowledge and interest in neuro-oncology. Nowadays the proper management of neuro-oncological patients requires specific experience and training. The EANO is a multidisciplinary and multiprofessional society aiming to provide science, standards of care, education, and communication. In this regard, EANO 2014 will give the opportunity to share the most up-to-date advances in basic science, translational and clinical research. All fields of neuro-oncology will be covered, such as biology and pathology, imaging, surgery, radiotherapy, chemotherapy, targeted therapies, supportive/palliative care and quality of life.
Turin is an attractive city located in Northern Italy between the Alps and the Mediterranean sea. Turin was the first Italian capital between 1861 and 1865 and its historical importance is shown by many architectural masterpieces, like the Mole Antonelliana, which is the hallmark of the city and the Reggia di Venaria, a Royal Residency. Moreover, the Egyptian Museum is the second most important in the world.
From the beginning of the 20th century, Turin became a strong industrial centre. The Lingotto building is an example of the industrial transformation of the city. In the last years, Turin changed once again its attitude and mood, hosting the 2006 Winter Olympics Games and becoming a more international and welcoming city.We look forward to welcoming you in Turin in 2014.
Group registrations not allowed
Accompanying persons not allowed
We don’t accept Online Abstracts
With the submission of an abstract to EANO XI, the presenting author:
- confirms that all authors are aware of and agree to the content of the abstract and support the data presented;
- accepts to be the contact person for all correspondence about the abstract and inform co-authors about its status;
- warrants that the data and conclusions presented in the abstract have not been published prior to the date of the EANO XI conference. Abstracts containing previously published material will be rejected;
- states that for studies involving human or animal subjects, permission has been obtained from the relevant regulatory authority, and properly informed consent give where appropriate;
- accepts responsibility for the accuracy of the submitted abstract;
- acknowledges that once the abstract is submitted, changes, corrections or rewording are possible until deadline of abstract submission (March 30, 2014);
- accepts the publication of the abstract within an issue of the Neuro-Oncology journal.
Careful typing and proof-reading are essential as the abstract will appear, if accepted, as submitted.
ACCEPTANCE AND SELECTION OF ABSTRACTS
All submitted abstracts will be reviewed by the Scientific Programme Committee in April 2014, and authors will be notified by email at the latest end of May 2014.
Abstract selection: Some accepted abstracts will be selected for oral presentation, some will be presented as posters.
Accepted abstracts will be published in an issue of the Neuro-Oncology journal.
AFFIRMATION REGARDING REGISTRATION
Important Note: At least 1 author (presenting author) of this abstract is obliged to register and pay the congress registration fee within 3 weeks (see congress website) after notification on acceptance. In the event of non-fulfillment the abstract will be withdrawn by the organizers.
- The abstract must be submitted in good English.
- The text must not exceed 2500 characters excluding spaces, title and authors.
- A maximum of two institutions per author is allowed.
- No more than 10 authors can be listed.
- No tables, no graphs or illustrations are allowed.
- No literature must be cited.
Please select only ONE topic that refers to the main subject of your abstract:01. Cell biology and signalling
03. Quality of life
04. Immunology and immunotherapy
05. In vitro / in vivo models
06. Molecular markers
07. New drug delivery methods
08. Neuroimaging of brain tumours
09. Glioblastoma and anaplastic gliomas
10. Low grade gliomas
11. Pediatric brain tumours
13. Spinal cord tumours
14. Brain and leptomeningeal metastases
15. Neurotoxicity and neuroprotection
16. Paraneoplastic neurological syndromes
17. Supportive and palliative care
18. Primary central nervous system lymphoma (PCNSL)
19. New developments in surgery
20. New developments in radiotherapy
Medizinische Ausstellungs- und Werbegesellschaft MAW
Mrs. Andrea Etz
1010 Vienna, Austria
Phone: +43 1 53663-42
Fax: +43 1 5356016
EANO XI Conference Secretariat
c/o Vienna Medical Academy
Alser Strasse 4
1090 Vienna, Austria
T: +43 1 4051383-10
F: +43 1 4078274